TSE:VBV VBI Vaccines (VBV) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1,300 shsAverage Volume3,637 shsMarket CapitalizationC$308.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get VBI Vaccines alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About VBI Vaccines Stock (TSE:VBV)VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.Read More Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. VBV Stock News HeadlinesAugust 15, 2024 | seekingalpha.comVBIVQ VBI Vaccines Inc.July 30, 2024 | marketwatch.comVBI Vaccines Starts Restructuring Procedure in CanadaSeptember 16, 2024 | Insiders Exposed (Ad)Has Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.April 16, 2024 | msn.comVBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023October 31, 2023 | morningstar.comVBI Vaccines Inc VBIVSeptember 26, 2023 | usatoday.comNo, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact checkSeptember 23, 2023 | usatoday.comUpdated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit mostSeptember 21, 2023 | nypost.comThe real data behind the new COVID vaccines the White House is pushingSeptember 16, 2024 | Insiders Exposed (Ad)Has Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.September 15, 2023 | nypost.comCOVID vaccine pill that kills virus before it infects the body could be comingAugust 30, 2023 | foxnews.comBiden plans to ask Congress for funding to develop new COVID vaccine, may recommend shot for allJuly 6, 2023 | msn.comVBI Vaccines slides on discounted stock and warrants offeringJuly 5, 2023 | marketwatch.comVBI Vaccines Shares Turn Lower, Erase After-Hours GainsJune 7, 2023 | msn.comVBI Vaccines gains ahead of upcoming presentation on hep B shotMay 15, 2023 | msn.comVBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue EstimatesApril 14, 2023 | msn.comRaymond James Maintains VBI Vaccines (VBIV) Outperform RecommendationApril 5, 2023 | marketwatch.comVBI Vaccines to Cut Workforce by 30%-35%, Focus on Hepatitis B >VBIVApril 5, 2023 | marketwatch.comVBI Vaccines Shares Plumb New Depths on Restructuring Plans >VBIVSee More Headlines Receive VBV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Biological Products, Except Diagnostic Substances Sub-IndustryPharmaceutical Products Current SymbolTSE:VBV CUSIPN/A CIKN/A Webwww.vbivaccines.com Phone+1-617-8303031FaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio14.29 Current Ratio2.64 Quick Ratio2.54 Sales & Book Value Annual SalesC$3.36 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueC$1.01 per share Price / BookN/AMiscellaneous Outstanding Shares64,079,000Free FloatN/AMarket CapC$308.86 million OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Jeff R. Baxter (Age 57)CEO, Pres & Director Dr. David Evander Anderson Ph.D. (Age 48)Chief Scientific Officer Ms. Athena Kartsaklis (Age 53)Sr. VP of Fin., Principal Financial & Accounting Officer, Chief Compliance Officer Ms. Nell Beattie (Age 30)Chief Bus. Officer Dr. Francisco Diaz-Mitoma M.D. (Age 63)Ph.D., Chief Medical Officer Key CompetitorsCronos GroupTSE:CRONTervitaTSE:TEVAbsolute Software Co. (ABT.TO)TSE:ABTNoront ResourcesCVE:NOTPyroGenesis Canada Inc. (PYR.V)CVE:PYRView All Competitors VBV Stock Analysis - Frequently Asked Questions How do I buy shares of VBI Vaccines? Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of VBI Vaccines own? Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Teladoc Health (TDOC), PhaseBio Pharmaceuticals (PHAS), Amarin (AMRN), Adverum Biotechnologies (ADVM), Assertio (ASRT), Activision Blizzard (ATVI) and Axsome Therapeutics (AXSM). This page (TSE:VBV) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VBI Vaccines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
